Vol 25, No 5 (2018)
Original articles — Clinical cardiology
Published online: 2017-07-10

open access

Page views 3591
Article views/downloads 1781
Get Citation

Connect on Social Media

Connect on Social Media

Quality of life in patients with coronary artery disease treated with coronary artery bypass grafting and hybrid coronary revascularization

Karolina Gierszewska1, Izabela Jaworska2, Michał Skrzypek3, Mariusz Gąsior1, Robert Pudlo4
Pubmed: 28695977
Cardiol J 2018;25(5):621-627.

Abstract

Background: Patients with stable coronary artery disease (CAD) have a worse quality of life (QoL) in comparison to patients without stable CAD. Standardized questionnaires are used in evaluation of QoL. Hybrid coronary revascularization (HCR) is a recently-introduced, minimally invasive option for patients requiring revascularization for coronary lesions. The aim of this study was to assess healthrelated quality of life (HRQoL) in patients with multivessel CAD (MVCAD), according to the mode of revascularization: coronary artery bypass grafting (CABG) or HCR, using the generic SF-36 v.2 questionnaire.

Methods: From November 2009 to July 2012, 200 patients from POLMIDES study with diagnosed MVCAD and were referred for conventional CABG were randomized to HCR (n = 98) or CABG (n =102) groups in 1:1 ratio. HRQoL were measured at two time points: hospital admission and 12-month follow up. The primary endpoint was the difference in HRQoL after the procedure.

Results: Both groups showed the same improvement of HRQoL: in HCR group: 13.5 (3.82–22.34) vs. CABG group: 10.48 (2.46–31.07); p = 0.76.

Conclusions: HRQoL in patients after both modes of revascularization significantly improved after 12 months in all domains.

Article available in PDF format

View PDF Download PDF file

References

  1. Gardner AW, Montgomery PS, Ritti-Dias RM, et al. Exercise performance, physical activity, and health-related quality of life in participants with stable angina. Angiology. 2011; 62(6): 461–466.
  2. Greenfield S, Nelson EC. Recent developments and future issues in the use of health status assessment measures in clinical settings. Med Care. 1992; 30(5 Suppl): MS23–MS41.
  3. Wilson IB, Cleary PD. Linking clinical variables with health-related quality of life. JAMA. 1995; 273(1): 59–65.
  4. Lam CLK. What is health-related quality of life (HRQOL)? Hong Kong Practitioner. 1997; 19: 505–506.
  5. Ware JE, Snow KK, Kosinski M. et al., SF-36 Health Survey: Manual and interpretation guide. The Health Institute, New England Medical Centre, Boston 1993.
  6. Ware JE, Kosinski MA, Keller SD. SF-36 Physical and Mental Component Summary Measures: a User’s Manual. The Health Institute New England Medical Center, Boston 1994.
  7. Cohen DJ, Van Hout B, Serruys PW, et al. Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery. N Engl J Med. 2011; 364(11): 1016–1026.
  8. Mathai SC, Suber T, Khair RM, et al. Health-related Quality of Life and Survival in Pulmonary Arterial Hypertension. Ann Am Thorac Soc. 2016; 13(1): 31–39.
  9. Sportelli E, Regesta T, Salsano A, et al. Does patient-prosthesis mismatch after aortic valve replacement affect survival and quality of life in elderly patients? J Cardiovasc Med (Hagerstown). 2016; 17(2): 137–143.
  10. Windecker S, Kolh P, Alfonso F, et al. 2014 ESC/EACTS Guidelines on myocardial revascularization. The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2014; 35: 2821–2830.
  11. Gosev I, Leacche M. Hybrid coronary revascularization: the future of coronary artery bypass surgery or an unfulfilled promise? Circulation. 2014; 130(11): 869–871.
  12. Gąsior M, Zembala MO, Tajstra M, et al. Hybrid revascularization for multivessel coronary artery disease. JACC Cardiovasc Interv. 2014; 7(11): 1277–1283.
  13. Zembala M, Tajstra M, Zembala M, et al. Prospective randomised pilOt study evaLuating the safety and efficacy of hybrid revascularisation in MultI-vessel coronary artery DisEaSe (POLMIDES) - study design. Kardiol Pol. 2011; 69(5): 460–466.
  14. Failde I, Ramos I. Validity and reliability of the SF-36 Health Survey Questionnaire in patients with coronary artery disease. J Clin Epidemiol. 2000; 53(4): 359–365.
  15. Dempster M, Donnelly M. Measuring the health related quality of life of people with ischaemic heart disease. Heart. 2000; 83(6): 641–644.
  16. Pocock SJ, Henderson RA, Seed P, et al. Quality of life, employment status and anginal symptoms after coronary angioplasty or bypass surgery. Circulation. 1996; 94: 135–142.
  17. Pocock SJ, Henderson RA, Clayton T, et al. Quality of life after coronary angioplasty or continued medical treatment for angina: three-year follow-up in the RITA-2 trial. J Am Coll Cardiol. 2000; 35: 907–914.
  18. Angelini GD, Wilde P, Salerno TA, et al. Integrated left small thoracotomy and angioplasty for multivessel coronary artery revascularisation. Lancet. 1996; 347(9003): 757–758.
  19. Bachinsky WB, Abdelsalam M, Boga G, et al. Comparative study of same sitting hybrid coronary artery revascularization versus off-pump coronary artery bypass in multivessel coronary artery disease. J Interv Cardiol. 2012; 25(5): 460–468.
  20. de Cannière D, Jansens JL, Goldschmidt-Clermont P, et al. Combination of minimally invasive coronary bypass and percutaneous transluminal coronary angioplasty in the treatment of double-vessel coronary disease: Two-year follow-up of a new hybrid procedure compared with "on-pump" double bypass grafting. Am Heart J. 2001; 142(4): 563–570.